Search results for " infarct"

showing 10 items of 1146 documents

Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium?

2006

Objectives: To assess the functional effects of multipotent adult progenitor cells (MAPCs) transplanted in a rat model of chronic myocardial infarction. Methods: Forty-four rats underwent coronary ligation and, 14 days later, were randomly allocated to receive in-scar injections (5×106 cells/150 μL) of green fluorescent protein (eGFP)-transduced allogeneic MAPCs ( n =25) or culture medium (controls, n =19). Nine of the MAPC-treated hearts were employed for functional studies while the remaining 16 received cells co-labeled with Resovist™ and were only used for serial histological assessments. Left ventricular (LV) function was assessed echocardiographically before transplantation and 1 mont…

Graft RejectionPathologymedicine.medical_specialtyEndotheliumPhysiologyMyocardial InfarctionBone Marrow CellsRats Sprague-DawleyPhysiology (medical)MedicineAnimalsMyocardial infarctionTreatment FailureProgenitor cellbusiness.industryMultipotent Stem CellsMyocardiummedicine.diseaseMyocardial ContractionRatsTransplantationmedicine.anatomical_structureMultipotent Stem CellModels AnimalImmunohistochemistryFemaleBone marrowStem cellCardiology and Cardiovascular MedicinebusinessCardiovascular research
researchProduct

Modernes Reperfusionsmanagement bei akutem Myokardinfarkt

2002

In der Regel liegt dem transmuralen Myokardinfarkt (ST-Hebungsinfarkt) die Ruptur einer atherosklerotischen Plaque mit nachfolgend thrombotischem Verschluss einer Koronararterie zugrunde. Seit Beginn der 1980er Jahre hat die Reperfusionstherapie bei akutem Myokardinfarkt zunehmend Eingang in die klinische Routine gefunden. Als Standardtherapie hat sich die intravenose Thrombolysetherapie durchgesetzt. Je fruhzeitiger die Reperfusion einsetzt, um so mehr Myokardgewebe kann vor der drohenden Nekrose bewahrt werden. Diese erzielbare Verringerung der Infarktgrose geht mit einer Verringerung der sonst drohenden linksventrikularen Funktionseinschrankung und einer Abnahme der Letalitat einher. Let…

Gynecologymedicine.medical_specialtybusiness.industryInternal MedicinemedicineMyocardial infarctionmedicine.diseasebusinessFibrinolytic agentDer Internist
researchProduct

Cardiovascular risk in patients without known cardiovascular disease.

2014

Understanding the risks of atherosclerotic cardiovascular disease (CVD) allows for better patient education and management. Multiple risk models have been validated in large patient populations and provide insights into the risks associated with CVD. When assessing such risks, we suggest using a model that predicts myocardial infarction, cardiovascular death, and/or cerebrovascular events. In this review, we analyze several risk models and stratify the risks associated with CVD. We suggest that appropriate profiling of patients at-risk of CVD will lead to better physician recognition and treatment of modifiable risk factors, appropriate application of ATP III treatment for hyperlipidemia, a…

Health Knowledge Attitudes PracticeRisk FactorModels TheoreticalCoronary heart diseaseMyocardial infarctionPatient Education as TopicCardiovascular DiseasesRisk FactorsCardiovascular DiseasePractice Guidelines as TopicBorderline risk factorHumansC Reactive ProteinCardiovascular multiple risk factorHumanEuropean review for medical and pharmacological sciences
researchProduct

The heart in the elderly critically ill patient

2002

Cardiac complications such as myocardial infarction and congestive heart failure are the primary source of perioperative morbidity and mortality in elderly surgical patients. This is the result of structural and functional age-related changes in the heart and the vasculature and an increasing incidence of cardiovascular disorders. Appropriate perioperative management of the elderly patient should be based on the extent of functional compromise, the type and severity of pre-existing disease, and the invasiveness of the surgical procedure. Current studies suggest that appropriately administered medical therapy, particularly beta-adrenergic blockade, may reduce perioperative cardiovascular mor…

Heart FailureAgingClinical Trials as Topicmedicine.medical_specialtyCritically illbusiness.industryCritical IllnessIncidence (epidemiology)Psychological interventionAnemiaHeartDiseasePerioperativeCritical Care and Intensive Care Medicinemedicine.diseasePerioperative CareBlockadeRisk FactorsHeart failuremedicineHumansMyocardial infarctionbusinessIntensive care medicineAgedCurrent Opinion in Critical Care
researchProduct

Early cardiac unloading with ImpellaCP™ in acute myocardial infarction with ventricular septal defect

2020

Abstract Despite a relative contraindication, mechanical support with Impella™ left ventricular assist device has already been described for ischaemic ventricular septal defect treatment, either as a bridge to surgery, as intraoperative mechanical haemodynamic support, or to ensure intraprocedural haemodynamic stability during device closure. We describe two cases of ventricular septal defect complicating acute myocardial infarction, where the percutaneous ImpellaCP was implanted early (differently than previously described) with the aim of preventing haemodynamic instability, while deferring surgical repair. We present a report of haemodynamic, echocardiographic, biochemical, and clinical …

Heart Septal Defects Ventricularmedicine.medical_specialtyPercutaneousAcute myocardial infarction mechanical complicationmedicine.medical_treatmentMyocardial InfarctionCase ReportLeft ventricular assist device610 Medicine & health030204 cardiovascular system & hematologyVentricular septal defectImpella11171 Cardiocentro Ticino2705 Cardiology and Cardiovascular Medicine03 medical and health sciences0302 clinical medicineInternal medicineDiseases of the circulatory (Cardiovascular) systemMedicineHumans030212 general & internal medicineMyocardial infarctioncardiovascular diseasesContraindicationImpellaSurgical repairbusiness.industryHemodynamicsAcute heart failureHeartPerioperativemedicine.diseaseRC666-701Heart failureVentricular assist deviceCardiologyHeart-Assist DevicesCardiology and Cardiovascular Medicinebusiness
researchProduct

SYMPTOMATIC ACUTE MYOCARDIAL INFARCTION IN A PATIENT BEARER OF HEART TRANSPLANTATION FOLLOWING ISCHEMIC HEART DISEASE

2008

In 2005 Syeda et al. reported that the major factor limiting the long term of cardiac transplantation is the development of accelerated arteriosclerosis that occurs in the coronary arteries of the cardiac allograft. Transplant arteriosclerosis is characterized by diffuse, uniform, concentric narrowing of the artery by a fibrous proliferation of sub-intima cells. This atherosclerosis was estimate to occur in approximately 50% of patients by 5 years after transplantation. Unfortunately, as a consequence of cardiac denervation, symptoms are often atypical or completely absent. When these are present, the symptoms are those typical of effort angina. Very uncommon is the acute coronary syndrome.…

Heart transplantationmedicine.medical_specialtyAcute coronary syndromeIschemic cardiomyopathybusiness.industrymedicine.medical_treatmentArteriosclerosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSurgeryCoronary artery diseaseTransplantationCoronary arteriessurgical procedures operativemedicine.anatomical_structureInternal medicineAtherosclerosis Heart transplantation Coronary artery diseasemedicineCardiologyMyocardial infarctionCardiology and Cardiovascular Medicinebusiness
researchProduct

Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for …

2019

Individuals with heterozygous familial hypercholesterolemia (FH) are at high risk of early myocardial infarction (MI). However, coronary artery disease (CAD) burden of FH remains not well described, especially for French patients.The objective of this study was to assess the prevalence of FH and severity of CAD from a large database of a French regional registry of acute MI.All consecutive patients hospitalized for an acute MI in a multicenter database from 2001 to 2017 were considered. FH was diagnosed using an algorithm adapted from the Dutch Lipid Clinic Network criteria. The prevalence and clinical features of FH and the severity of CAD were assessed.Among the 11,624 patients included i…

Heterozygotemedicine.medical_specialtyEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]Myocardial InfarctionFamilial hypercholesterolemia030204 cardiovascular system & hematologySeverity of Illness IndexCohort StudiesHyperlipoproteinemia Type IICoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinePrevalenceInternal MedicinemedicineHumansIn patientRegistries030212 general & internal medicineMyocardial infarctionRisk factorAcute miLipid clinicAgedAged 80 and overNutrition and Dieteticsbusiness.industryCholesterol LDLMiddle AgedEzetimibemedicine.disease3. Good healthLarge cohortHospitalizationFranceHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular Medicinebusiness
researchProduct

Admission glycemia and in-hospital death following cardiac arrest during myocardial infarction outside hospital

2013

In hospital deathCoronary angiographymedicine.medical_specialtyEjection fractionbusiness.industryHospital mortalitymedicine.diseaseInternal medicineDiabetes mellitusmedicineCardiologyMyocardial infarctionCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

In vivo and ex vivo magnetic resonance spectroscopy of the infarct and the subventricular zone in experimental stroke

2015

Ex vivo high-resolution magic-angle spinning (HRMAS) provides metabolic information with higher sensitivity and spectral resolution than in vivo magnetic resonance spectroscopy (MRS). Therefore, we used both techniques to better characterize the metabolic pattern of the infarct and the neural progenitor cells (NPCs) in the ipsilateral subventricular zone (SVZi). Ischemic stroke rats were divided into three groups: G0 (non-stroke controls, n = 6), G1 (day 1 after stroke, n = 6), and G7 (days 6 to 8 after stroke, n =12). All the rats underwent MRS. Three rats per group were analyzed by HRMAS. The remaining rats were used for immunohistochemical studies. In the infarct, both techniques detect…

In vivo magnetic resonance spectroscopyBrain InfarctionMalePathologymedicine.medical_specialtyMRSspectroscopyMagnetic Resonance SpectroscopyTime FactorsHRMASSubventricular zoneRats Sprague-DawleyIn vivoLateral VentriclesmedicineAnimalsStrokebusiness.industryNeurogenesismedicine.diseasestrokeNeural stem cellRatsStrokeneurogenesisDisease Models Animalmedicine.anatomical_structureNeurologyBiomarker (medicine)Original ArticleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessNeuroscienceEx vivoBiomarkers
researchProduct

Evaluation of the Haemorheological Determinants in Coronary Heart Disease

1984

Increased blood viscosity has been described in patients with coronary artery disease (1, 2, 3, 4, 5, 6, 7, 8).

Increased blood viscosityCoronary artery diseasemedicine.medical_specialtybusiness.industryInternal medicineBlood viscosityCardiologyMedicineIn patientMyocardial infarctionbusinessmedicine.diseaseCoronary heart disease
researchProduct